You are here

Article Text

Article menu
Download PDFPDF
Rare disease
CASE REPORT
Retrovesical malignant fibrous histiocytoma: a rare tumor
  1. Shuchita Pathak1,
  2. Tej Prakash Soni1,
  3. Anil Kumar Gupta2,
  4. Lalit Mohan Sharma3
  1. 1Radiation Oncology, Bhagwan Mahaveer Cancer Hospital and Research Centre, Jaipur, India
  2. 2Surgical Oncology, Bhagwan Mahaveer Cancer Hospital and Research Centre, Jaipur, India
  3. 3Medical Oncology, Bhagwan Mahaveer Cancer Hospital and Research Centre, Jaipur, India
  1. Correspondence to Dr Tej Prakash Soni, drtejprakashsoni{at}yahoo.co.in

Summary

Malignant fibrous histiocytoma (MFH) originating from the retrovesical space is a very rare tumour. A 61-year-old man presented to our hospital with complaints of retention of urine and burning sensation during micturition since 6 months. CT scan abdomen showed a large retrovesical mass between the urinary bladder and rectum, measuring 11×9×12 cm, displacing the urinary bladder. Serum PSA (Prostate Specific Antigen) value was within normal range. Biopsy from retrovesical mass and immunohistochemistry was suggestive of MFH. Wide excision of the retrovesical mass was done. Histopathology confirmed the diagnosis of MFH. He received adjuvant radiotherapy. He is on regular follow-up since the last 2 years after radiotherapy with no signs and symptoms of disease recurrence.

  • pathology
  • radiotherapy
  • oncology

https://doi.org/10.1136/bcr-2017-222612

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors SP, TPS, AKG, LMS: substantial contributions to the conception or design of the work, or the acquisition, analysis or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

    • Competing interests None declared.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.